GLUTABLISS 600 MG INJECTION contains Glutathione which belongs to the group of medicines called Antioxidants. It is used to treat alcoholic fatty liver (disease that occurs due to heavy alcohol use), liver fibrosis/cirrhosis (scarring of liver due to excessive consumption of alcohol), and hepatitis (inflammation of liver) in affected individuals.
GLUTABLISS 600 MG INJECTION is not recommended for use in patients allergic to Glutathione. Before receiving GLUTABLISS 600 MG INJECTION, inform your doctor if you suffer from liver problems (such as chronic hepatitis), and kidney problems (such as acute renal failure).
GLUTABLISS 600 MG INJECTION is not recommended for use in pregnant and breastfeeding women unless it is clearly necessary. It should be used with caution in neonates, premature infants, children, and adolescents (aged below 18 years) and is advised to be used with caution in elderly patients (aged 70 years and above) after consulting the doctor.
The most common side effects of receiving GLUTABLISS 600 MG INJECTION are anorexia (eating disorder), nausea, vomiting, and/or rash. Consult your doctor if any of these symptoms worsens.
Treats:
GLUTABLISS 600 MG INJECTION is an antioxidant which works by directly quenching reactive hydroxyl free radicals or other free radicals which prevents damage to the liver cells thus treating alcoholic liver disease in affected individuals.
GLUTABLISS 600 MG INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion or into the muscle as an intramuscular injection. Your doctor will decide the correct dose and duration of treatment depending upon your age, body weight and disease condition.
Stop receiving GLUTABLISS 600 MG INJECTION and consult your doctor immediately in case you experience:
Receive GLUTABLISS 600 MG INJECTION with/just after a meal. Stick to simple meals. Avoid eating oil rich/spicy foods, sugary snacks and drinks. Avoid drinking too much liquid along with your meals, and drink slowly in between meals. Consult your doctor if the condition worsens.
GLUTABLISS 600 MG INJECTION is not recommended for use in pregnant women unless it is clearly necessary. Consult your doctor before receiving the medicine.
GLUTABLISS 600 MG INJECTION is not recommended for use in breastfeeding women unless it is clearly necessary. Consult your doctor before receiving the medicine.
GLUTABLISS 600 MG INJECTION should be used with caution in patients with kidney problems such as acute renal failure. Consult your doctor before receiving the medicine.
GLUTABLISS 600 MG INJECTION should be used with caution in patients with liver problems such as chronic hepatitis B. Consult your doctor before receiving the medicine.
Do not receive GLUTABLISS 600 MG INJECTION if you are allergic to Glutathione, and/or any other ingredients of this medicine.
Use in Paediatrics:
GLUTABLISS 600 MG INJECTION should be used with caution in neonates, premature infants, children, and adolescents (aged below 18 years). Consult your doctor before receiving the medicine.
Use in Geriatric:
GLUTABLISS 600 MG INJECTION should be used with caution in elderly patients (aged 70 years and above). Consult your doctor before receiving the medicine.
A. Drug-Drug interactions:
Before receiving GLUTABLISS 600 MG INJECTION, inform your doctor if you are taking any of the following medicine:
Overdosage:
GLUTABLISS 600 MG INJECTION will be administered to you only by a doctor or a nurse in a hospital, and so it is unlikely to receive an overdose. However, consult your doctor or nurse immediately if you experience any unusual symptoms.
Drug | : | Glutathione |
Pharmacological Category | : | Antioxidant |
Therapeutic Indication | : | Alcoholic fatty liver, liver fibrosis/cirrhosis, hepatitis |
Dosage Forms | : | Injection, Tablet, Capsule |
Q. What is GLUTABLISS 600 MG INJECTION used for?
A. GLUTABLISS 600 MG INJECTION is used to treat alcoholic fatty liver (disease that occurs due to heavy alcohol use), liver fibrosis/cirrhosis (scarring of liver due to excessive consumption of alcohol), and hepatitis (inflammation of liver) in affected individuals.
Q. What happens if GLUTABLISS 600 MG INJECTION is administered more than its required dosage?
A. GLUTABLISS 600 MG INJECTION will be administered to you only by a doctor or a nurse in a hospital, and so it is unlikely to receive an overdose. However, consult your doctor or nurse immediately if you experience any unusual symptoms.
Q. What are the side effects of GLUTABLISS 600 MG INJECTION?
A. The most common side effects of receiving GLUTABLISS 600 MG INJECTION are anorexia (eating disorder), nausea, vomiting, and/or rash. Consult your doctor if any of these symptoms worsens.
Q. How GLUTABLISS 600 MG INJECTION works?
A. GLUTABLISS 600 MG INJECTION is an antioxidant which works by directly quenching reactive hydroxyl free radicals or other free radicals which prevents damage to the liver cells thus treating alcoholic liver disease in affected individuals.
Q. How GLUTABLISS 600 MG INJECTION is administered?
A. GLUTABLISS 600 MG INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion or into the muscle as an intramuscular injection. Your doctor will decide the correct dose and duration of treatment depending upon your age, body weight and disease condition.
1. Murray M.Fisher. Ethanol metabolites in hepatic lipid peroxidation. Alcohol and Liver. Edition: November 2013. Page – 53.
2. Yasushi Honda, Takaomi Kessoku, Yoshio Sumida, Takashi Kobayashi, Takayuki Kato, Yuji Ogawa, Wataru Tomeno, Kento Imajo, Koji Fujita, Masato Yoneda, Koshi Kataoka, Masataka Taguri, Takeharu Yamanaka, Yuya Seko, Saiyu Tanaka, Satoru Saito, Masafumi Ono, Satoshi Oeda, Yuichiro Eguchi, Wataru Aoi, Kenji Sato, Yoshito Itoh, Atsushi Nakajima. Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. August 2017. [Accessed on 14th November 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549431/
3. Li Qian, Wenjun Wang, Yan Zhou, Jianxin Ma. Effects of reduced glutathione therapy on chronic hepatitis B. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. May 2017. [Accessed on 14th November 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470607/
4. Zuventus Healthcare Ltd. Maxiliv Injection. [Accessed on 14th November 2022] http://www.zuventus.co.in/doctor_wise_products_selected.aspx?Medi_Id=357
5. C Costagliola, L Romano, G Scibelli, A de Vincentiis, P Sorice, A Di Benedetto. Anemia and chronic renal failure: a therapeutical approach by reduced glutathione parenteral administration. NIH National Library of Medicine. National Center for Biotechnology Information. PubMed.gov. 1992. [Accessed on 14th November 2022] https://pubmed.ncbi.nlm.nih.gov/1501736/
Additional Discount on this product
Please get a call back from our expert
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.